Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of (R)-Suprofen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 known ✓ | P35354 | 8/20 | 1.00 |
| ▸ | PTGS1 known ✓ | P23219 | 7/20 | 1.00 |
| ▸ | HPGD | P15428 | 7/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 1.00 |
| ▸ | HPGDS | O60760 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (S)-Suprofen SCHEMBL5102821 | 1.00 | PTGS2 (1.00) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| Suprofen SCHEMBL23792 | 1.00 | PTGS2 (1.00) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| Suprofen SCHEMBL9621599 | 0.98 | PTGS2 (0.97) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| Suprofen SCHEMBL3971318 | 0.97 | PTGS2 (0.94) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| Suprofen SCHEMBL3262801 | 0.97 | PTGS2 (0.94) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| SCHEMBL12286991 | 0.91 | HPGD (0.83) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| Suprofen SCHEMBL11706680 | 0.91 | PTGS2 (0.82) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| SCHEMBL14213389 | 0.88 | HPGD (0.78) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| Suprofen SCHEMBL3971317 | 0.86 | PTGS1 (0.74) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 | |
| SCHEMBL11703369 | 0.86 | HPGD (0.76) | PTGS2HPGDPTGS1CYP2C9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3796895-B1 | BIOMIMETIC VESICLES AND USES THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-02-14 | — | — | EP | claimed |
| EP-3682872-B1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-01-03 | — | — | EP | claimed |
| EP-3708178-B1 | PEPTIDE FOR USE IN PREVENTING OR TREATING MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC (US) | 2023-10-04 | — | — | EP | claimed |
| EP-3344232-B1 | MICELLES FOR MUCOADHESIVE DRUG DELIVERY | UNIV MCMASTER (CA) | 2022-01-26 | — | — | EP | claimed |
| EP-3660013-B1 | SGC STIMULATORS | CYCLERION THERAPEUTICS INC (US) | 2022-01-19 | — | — | EP | claimed |
| EP-3626713-B1 | CYCLOPROPYLAMINES FOR USE AS LSD1 INHIBITORS | INCYTE CORP (US) | 2021-09-29 | — | — | EP | claimed |
| EP-3279663-B1 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | BRIGHAM & WOMENS HOSPITAL INC (US) | 2021-07-28 | — | — | EP | claimed |
| EP-3578172-B1 | SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION | INFIRST HEALTHCARE LTD (GB) | 2021-03-24 | — | — | EP | claimed |
| EP-2841066-B1 | ANTI-INFLUENZA AGENT CONJUGATED TO ANTI-INFLAMMATORY AGENT | ACADEMIA SINICA (TW) | 2021-02-17 | — | — | EP | claimed |
| EP-2968223-B1 | PHENYLEPHRINE RESINATE PARTICLES | JOHNSON & JOHNSON CONSUMER INC (US) | 2020-10-28 | — | — | EP | claimed |
| EP-0225162-B1 | INHIBITION OF POST-SURGICAL ADHESION FORMATION BY THE TOPICAL ADMINISTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG | ETHICON, INC. (US) | 1992-01-22 | — | — | EP | claimed |
| EP-0212745-B1 | DRUG PARTICLES HAVING CONSTANT RELEASE | THE PROCTER & GAMBLE COMPANY (US) | 1991-04-10 | — | — | EP | claimed |
| EP-0212746-B1 | DRUG PARTICLES HAVING CONSTANT RELEASE | THE PROCTER & GAMBLE COMPANY (US) | 1991-04-10 | — | — | EP | claimed |
| EP-0212747-B1 | DRUG PARTICLES HAVING CONSTANT RELEASE AND IMMEDIATE RELEASE | THE PROCTER & GAMBLE COMPANY (US) | 1991-04-10 | — | — | EP | claimed |
| EP-0205215-B1 | PROCESS FOR THE PREPARATION OF 2-ARYLPROPIONIC ACIDS | GIST-BROCADES N.V. (NL) | 1990-08-08 | — | — | EP | claimed |
| EP-0105635-B1 | NONIRRITATING AQUEOUS OPHTHALMIC COMPOSITIONS COMFORT FORMULATION FOR OCULAR THEREPEUTIC AGENTS | ALCON LABORATORIES, INC. (US) | 1990-04-04 | — | — | EP | claimed |
| EP-0335785-A1 | Hydrogel-type polymer supports with releasable active agents, corresponding compositions, and a process for their preparation | ESSILOR INTERNATIONAL Compagnie Générale d'Optique (FR) | 1989-10-04 | — | — | EP | claimed |
| EP-0114886-B1 | IMPROVED ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CAFFEINE | SUNSHINE, Abraham (US) | 1987-09-30 | — | — | EP | claimed |
| EP-0109036-B1 | ANTI-INFLAMMATORY/ANALGESIC COMBINATION OF ALPHA-FLUOROMETHYLHISTIDINE AND A SELECTED NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) | MERCK & CO. INC. (US) | 1987-09-02 | — | — | EP | claimed |
| EP-0072462-B1 | PHARMACEUTICAL PREPARATIONS | Toko Yakuhin Industry Co., Ltd. (JP) | 1986-10-29 | — | — | EP | claimed |